TY  - GEN 
AU  - Ruiz-Villaverde, Ricardo
AU  - Rodriguez Fernández-Freire, L.
AU  - Galán-Gutiérrez, Manuel
AU  - Armario Hita, José Carlos
AU  - Martínez-Pilar, L.
A4  - Medicina
PY  - 2021
SN  - 1578-2190
UR  - http://hdl.handle.net/10498/26335
AB  - Secukinumab, an immunoglobulin G1/  monoclonal antibody that selectively targets
interleukin 17a, is used to treat moderate to severe plaque psoriasis in adults who are eligible
for systemic treatment. Indirect comparisons of the efficacy of...
LA  - eng
PB  - ELSEVIER
KW  - Secukinumab
KW  - Drug survival
KW  - Psoriasis
TI  - Secukinumab: Drug Survival in Clinical Practice Settings
DO  - 10.1016/j.adengl.2021.01.031
ER  -